Cargando…
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
Ovarian cancer (OC) is the second most common cause of death in women with gynecological cancer. Considering the poor prognosis, particularly in the case of platinum-resistant (PtR) disease, a huge effort was made to define new biomarkers able to help physicians in approaching and treating these cha...
Autores principales: | Sassu, Carolina Maria, Palaia, Innocenza, Boccia, Serena Maria, Caruso, Giuseppe, Perniola, Giorgia, Tomao, Federica, Di Donato, Violante, Musella, Angela, Muzii, Ludovico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707281/ https://www.ncbi.nlm.nih.gov/pubmed/34948446 http://dx.doi.org/10.3390/ijms222413650 |
Ejemplares similares
-
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
por: Caruso, Giuseppe, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
por: Musacchio, Lucia, et al.
Publicado: (2020) -
Ovarian Cancer Metastasis to the Breast: A Case Report and Review of the Literature
por: Caruso, Giuseppe, et al.
Publicado: (2020) -
Expectant, Medical, and Surgical Management of Ovarian Endometriomas
por: Muzii, Ludovico, et al.
Publicado: (2023) -
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research
por: Tomao, Federica, et al.
Publicado: (2020)